Immatics (IMTX) Revenue & Revenue Breakdown
Immatics Revenue Highlights
Latest Revenue (Y)
$54.00M
Latest Revenue (Q)
$30.45M
Immatics Revenue by Period
Immatics Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | -68.76% |
2022-12-31 | - | 397.17% |
2021-12-31 | - | 11.23% |
2020-12-31 | - | 69.40% |
2019-12-31 | - | 389.36% |
2018-12-31 | - | - |
Immatics Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-03-31 | - | 91.24% |
2023-12-31 | - | 168.66% |
2023-09-30 | - | -73.49% |
2023-06-30 | - | 128.20% |
2023-03-31 | - | -73.98% |
2022-12-31 | - | 149.99% |
2022-09-30 | - | -12.52% |
2022-06-30 | - | -83.27% |
2022-03-31 | - | 554.33% |
2021-12-31 | - | 144.09% |
2021-09-30 | - | 24.17% |
2021-06-30 | - | -29.91% |
2021-03-31 | - | -21.63% |
2020-12-31 | - | 20.01% |
2020-09-30 | - | 14.14% |
2020-06-30 | - | -2.05% |
2020-03-31 | - | 60.58% |
2019-12-31 | - | -13.29% |
2019-09-30 | - | -6.09% |
2019-06-30 | - | 16.73% |
2019-03-31 | - | 389.36% |
2018-12-31 | - | - |
2018-09-30 | - | - |
2018-06-30 | - | - |
2018-03-31 | - | - |
Immatics Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
HRMY | Harmony Biosciences | - | - |
IMTX | Immatics | - | - |
MRUS | Merus | - | - |
FENC | Fennec Pharmaceuticals | - | - |
JANX | Janux Therapeutics | - | - |
KRON | Kronos Bio | - | - |
CRNX | Crinetics Pharmaceuticals | - | - |
INBX | Inhibrx Biosciences | - | - |
KROS | Keros Therapeutics | - | - |
LYEL | Lyell Immunopharma | - | - |
ALXO | ALX Oncology | - | - |
BCAB | BioAtla | - | - |
AVTE | Aerovate Therapeutics | - | - |
REPL | Replimune Group | - | - |
SNDX | Syndax Pharmaceuticals | - | - |
MLYS | Mineralys Therapeutics | - | - |
EWTX | Edgewise Therapeutics | - | - |